NO942075L - Rekombinante virus omfattende kunstig proteolytisk spaltingssete - Google Patents

Rekombinante virus omfattende kunstig proteolytisk spaltingssete

Info

Publication number: NO942075L
Authority: NO; Norway
Prior art keywords: recombinant viruses; cleavage site; proteolytic cleavage; replication; viruses including
Prior art date: 1991-12-06

Application number

NO942075A

Other languages

English (en)

Norwegian (no)

Other versions

NO942075D0 (no

Inventor

Mark Feinberg

Raul Andino

Carolyn Louise Weeks-Levy

Patricia Anne Reilly

Original Assignee

Whitehead Biomedical Inst

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-06

Filing date

1994-06-03

Publication date

1994-08-03

1994-06-03 Application filed by Whitehead Biomedical Inst, American Cyanamid Co filed Critical Whitehead Biomedical Inst

1994-06-03 Publication of NO942075D0 publication Critical patent/NO942075D0/no

1994-08-03 Publication of NO942075L publication Critical patent/NO942075L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Zoology (AREA)
Virology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO942075A 1991-12-06 1994-06-03 Rekombinante virus omfattende kunstig proteolytisk spaltingssete NO942075L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US80489391A	1991-12-06	1991-12-06
US94779092A	1992-09-18	1992-09-18

Publications (2)

Publication Number	Publication Date
NO942075D0 NO942075D0 (no)	1994-06-03
NO942075L true NO942075L (no)	1994-08-03

Family

ID=27122734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO942075A NO942075L (no)	1991-12-06	1994-06-03	Rekombinante virus omfattende kunstig proteolytisk spaltingssete

Country Status (20)

Country	Link
EP (1)	EP0672157B1 (sv)
JP (1)	JPH07502403A (sv)
KR (1)	KR100272419B1 (sv)
CN (1)	CN1055726C (sv)
AT (1)	ATE206762T1 (sv)
AU (1)	AU674134B2 (sv)
CA (1)	CA2123804A1 (sv)
CZ (1)	CZ127394A3 (sv)
DE (1)	DE69232122T2 (sv)
DK (1)	DK0672157T3 (sv)
ES (1)	ES2163405T3 (sv)
FI (1)	FI942623L (sv)
HU (1)	HUT67346A (sv)
IL (1)	IL104003A0 (sv)
MX (1)	MX9206981A (sv)
NO (1)	NO942075L (sv)
NZ (1)	NZ246276A (sv)
PT (1)	PT672157E (sv)
TW (1)	TW403784B (sv)
WO (1)	WO1993011251A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997012048A1 (en) *	1995-09-27	1997-04-03	Medical Research Council	Recombinant viruses incorporating a protease cleavable protein
FI20075063A0 (sv)	2007-02-01	2007-02-01	Vactech Oy	Prevention av allergisk sensibilisering
MX2020009720A (es)	2018-03-19	2021-01-08	Boehringer Ingelheim Vetmedica China Co Ltd	Virus recombinante capaz de expresar de manera estable proteinas objetivo.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1293591C (en) *	1985-01-11	1991-12-24	Charles A. Kettner	Peptide substrates for detecting virus-specified protease activity
ES2059482T3 (es) *	1987-12-23	1994-11-16	Boehringer Ingelheim Int	Expresion de la proteasa p2a de hrv2 codificada por virus.
CA1340378C (en) *	1988-02-26	1999-02-02	Laurence K. Grill	Non-nuclear chromosomal transformation
DD275259A1 (de) *	1988-08-30	1990-01-17	Akad Wissenschaften Ddr	Verfahren zur konstruktion eines neuen expressionsvektors
WO1990011359A1 (en) *	1989-03-20	1990-10-04	Whitehead Institute For Biomedical Research	Intracellular method of inhibiting hiv in mammalian cells
GB8912496D0 (en) *	1989-05-31	1989-07-19	Medical Res Council	Vaccines
EP0478588A1 (en) *	1989-05-31	1992-04-08	Medical Research Council	Poliovirus chimaeras
ATE177786T1 (de) *	1990-05-28	1999-04-15	Univ Osaka Res Found	Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt
CA2072154A1 (en) *	1990-08-28	1992-03-01	Wolfgang Sommergruber	Test system for checking the activity of viral proteinases

1992
- 1992-12-03 MX MX9206981A patent/MX9206981A/es unknown
- 1992-12-04 JP JP5510379A patent/JPH07502403A/ja active Pending
- 1992-12-04 PT PT93900925T patent/PT672157E/pt unknown
- 1992-12-04 AU AU32424/93A patent/AU674134B2/en not_active Ceased
- 1992-12-04 CA CA002123804A patent/CA2123804A1/en not_active Abandoned
- 1992-12-04 DE DE69232122T patent/DE69232122T2/de not_active Expired - Fee Related
- 1992-12-04 CN CN92115173A patent/CN1055726C/zh not_active Expired - Fee Related
- 1992-12-04 IL IL104003A patent/IL104003A0/xx unknown
- 1992-12-04 KR KR1019940701920A patent/KR100272419B1/ko not_active IP Right Cessation
- 1992-12-04 NZ NZ246276A patent/NZ246276A/en unknown
- 1992-12-04 CZ CZ941273A patent/CZ127394A3/cs unknown
- 1992-12-04 AT AT93900925T patent/ATE206762T1/de not_active IP Right Cessation
- 1992-12-04 ES ES93900925T patent/ES2163405T3/es not_active Expired - Lifetime
- 1992-12-04 WO PCT/US1992/010543 patent/WO1993011251A1/en active IP Right Grant
- 1992-12-04 EP EP93900925A patent/EP0672157B1/en not_active Expired - Lifetime
- 1992-12-04 HU HU9401689A patent/HUT67346A/hu unknown
- 1992-12-04 DK DK93900925T patent/DK0672157T3/da active
1993
- 1993-03-16 TW TW082101918A patent/TW403784B/zh not_active IP Right Cessation
1994
- 1994-06-03 NO NO942075A patent/NO942075L/no not_active Application Discontinuation
- 1994-06-03 FI FI942623A patent/FI942623L/sv unknown

Also Published As

Publication number	Publication date
FI942623L (sv)	1994-07-21
KR100272419B1 (ko)	2001-02-01
ATE206762T1 (de)	2001-10-15
CN1055726C (zh)	2000-08-23
AU674134B2 (en)	1996-12-12
PT672157E (pt)	2002-04-29
DK0672157T3 (da)	2001-12-03
KR950700421A (ko)	1995-01-16
MX9206981A (es)	1994-08-31
DE69232122T2 (de)	2002-05-16
FI942623A0 (sv)	1994-06-03
WO1993011251A1 (en)	1993-06-10
HUT67346A (en)	1995-03-28
DE69232122D1 (de)	2001-11-15
JPH07502403A (ja)	1995-03-16
NZ246276A (en)	1996-08-27
ES2163405T3 (es)	2002-02-01
AU3242493A (en)	1993-06-28
EP0672157B1 (en)	2001-10-10
IL104003A0 (en)	1993-05-13
CA2123804A1 (en)	1993-06-10
CN1075334A (zh)	1993-08-18
TW403784B (en)	2000-09-01
NO942075D0 (no)	1994-06-03
CZ127394A3 (en)	1995-11-15
HU9401689D0 (en)	1994-09-28
EP0672157A1 (en)	1995-09-20

Publication	Publication Date	Title
EE05138B1 (et)	2009-02-16	Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin
RU94038050A (ru)	1996-05-10	Рекомбинантный вирус, вектор, вакцина, способ иммунизации, клетка-хозяин
DE68919846D1 (de)	1995-01-19	Poxvirus-vektoren.
ATE451835T1 (de)	2010-01-15	Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae
DK0437604T3 (da)	2003-09-15	Rekombinant poxvirus- og streptokok M-proteinvaccine
FI935459A0 (fi)	1993-12-07	Deletionsmutanter av noetkreaturens herpesvirus typ 1, vaccin baserade daerpao; diagnostiska redskap foer upptaeckande av deletionsmutanter av noetkreaturens herpesvirus typ 1
UA82998C2 (ru)	2008-06-10	Экспрессия генов в модифицированном вирусе коровьей оспы ankara с использованием коровьего поксвирусного промотора аті
NO177716C (no)	1995-11-08	Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
TW377373B (en)	1999-12-21	Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ES2130189T3 (es)	1999-07-01	Vacunas de virus sincitial respiratorio (rsv) mutante que contienen dicho virus y procedimientos de uso.
NO954135D0 (no)	1995-10-17	Fiskebukspyttkjertel-sykdomsvirus
SE9903031D0 (sv)	1999-08-27	Peptide mixture and vaccine against a chronic viral infection
HUP9901005A2 (hu)	1999-07-28	Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
NO942075L (no)	1994-08-03	Rekombinante virus omfattende kunstig proteolytisk spaltingssete
NO964874L (no)	1996-11-15	Fusjonsglykoprotein fra HCMV og HSV
BR0310020A (pt)	2005-02-15	Expressão de genes no vìrus da vacìnia modificado ancara por uso do promotor de ati de vacìnia
DE69736779D1 (de)	2006-11-16	Zusammensetzungen von rekombinanten papillomavirus vakzinen
FI923020A0 (fi)	1992-06-29	Inte a inte b-sekvenser.
ATE109158T1 (de)	1994-08-15	Rubella-e1 und c peptide.
AU2190288A (en)	1989-03-09	Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
AR248047A1 (es)	1995-05-31	Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
RU95109909A (ru)	1997-03-27	Способ ингибирования ретровирусной инфекции, ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора
RU94030478A (ru)	1996-07-27	Рекомбинантный вирус, способ его получения, способ иммунизации, способ получения протеина, вакцинная композиция, применение рекомбинантного вируса
WO1992014818A3 (en)	1992-12-10	Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
PL442478A1 (pl)	2024-04-15	Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych

Legal Events

Date	Code	Title	Description
2003-08-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application